India, May 15 -- Tango Therapeutics, Inc. (TNGX) shares dropped 16.93 percent to $20.66, down $4.21 on Friday, after the biotechnology company reported a wider first-quarter loss, as collaboration revenue fell to zero.
The stock is currently trading at $20.66, compared with a previous close of $24.87 on the Nasdaq. It opened at $23.10 and traded between $20.60 and $23.30 during the session, with volume reaching 1.68 million shares, below the average daily volume of 3.35 million shares.
Collaboration revenue was $0 in the first quarter of 2026, compared with $5.4 million in the same period last year. Net loss widened to $45.5 million, or $0.32 per share, from $39.9 million, or $0.36 per share, a year earlier. Loss from operations increased...